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Background & objectives: Cytokines play an important role in anti-tuberculosis immune response.
Skewing of immunity from protective to pathogenic may involve a shift in Th1-Th2 paradigm.
Cytokine gene polymorphism is known to be associated with functional differences in cytokine
regulation and altered clinical performance in a variety of diseases. The aim of this study was to
know whether Interleukin-12B 3’ UTR (Taq1) (A/C) and Interleukin-10 (-1082 G/A) gene
polymorphisms were associated with susceptibility to pulmonary tuberculosis.
Methods: IL -10 (-1,082 G/A) and IL-12B gene polymorphisms were studied in132 pulmonary TB
(PTB) patients and 143 normal healthy subjects (NHS), using DNA based polymerase chain reaction
(PCR) with sequence specific primers and restriction digestion.
Results: The allelic as well as genotypic frequencies of Interleukin -10 (-1082) and Interleukin -12B
(3’UTR Taq 1) did not differ significantly between the patients and controls.
Interpretation & conclusion: Our findings suggested that IL -10 (-1082 G/A) and IL -12B 3’UTR
(Taq I) (A/C) gene polymorphisms were not associated either with susceptibility or resistance to
pulmonary tuberculosis in the south Indian population.
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Mycobacterium tuberculosis is responsible for at
least 1.5 million deaths per year worldwide. One third
of the world’s population is infected with M.
tuberculosis1. But development of tuberculosis
depends on complex environmental factors and host
genetic factors. Case control  studies have found
significant associations between tuberculosis and
gene polymorphisms like human leukocyte antigen
(HLA)2 and non-HLA genes such as natural resistance
associated macrophage protein (NRAMP1)3, vitamin
D receptor (VDR)4,  mannose binding lectin (MBL)5,
interleukin-1 (IL-1)6, IL-107 and IL-12 receptor8.
Interaction between the pathogen and host immune
response probably determines the development or
resistance to tuberculosis.  Moreover, cytokines play
an important role in anti-tuberculosis immune
response9. Studies on mouse models have equated Th1
response to protective cell-mediated immunity and
Th2 response to disease status10,11. IL-12 is a
regulatory cytokine which connects the innate and
135
Indian J Med Res 126, August 2007, pp 135-138
136 INDIAN J MED RES, AUGUST 2007
adaptive host response to mycobacterium and exerts
its effects mainly through induction of interferon
gamma (IFN-γ)12. Deleterious mutations in genes of
IL-12B encoding IL-12p40, a subunit of IL-12 and
IL-12R have been shown to be associated with
susceptibility to infections caused by poorly
pathogenic mycobacterium13. Studies also have shown
that IL-10, a Th2 cytokine is a potent inhibitor of T
cell functions, Major histocompatibility complex
(MHC) class II expression, antigen specific
proliferation and IFN-γ synthesis14. Moreover, IL-10
is inversely correlated in human tuberculosis15.  Hence
allelic variations in the coding as well as regulatory
regions of IL-10 and IL-12B genes that are associated
with differential cytokine levels might be expected
to have an impact on susceptibility to tuberculosis.
In this study, we therefore investigated IL-10 (-1082
G/A) and IL-12B (3’UTR, Taq1 A/C) gene
polymorphisms in pulmonary tuberculosis (PTB)
patients and normal healthy subjects in south India.
Material & Methods
Patients attending Tuberculosis Research Centre
(TRC), Chennai, from January 2004 to December
2005, with respiratory symptoms and radiographic
abnormalities suggestive of PTB and sputum positive
for M. tuberculosis by both smear and culture were
included. Normal healthy subjects (NHS) included
were staffs, trainees and students of TRC who
volunteered to donate blood, were clinically normal
at the time of blood collection. The study group
consisted of 132 PTB patients (mean age + SD: 35.5
+ 12.3 yr) and 143 NHS (mean age + SD: 29.7 + 9.5
yr). Among the 132 patients, 75 were males and in
143 NHS, 84 were males. The patients and the healthy
normal subjects were south Indian Tamil speaking
population of Dravidian descent living in and around
Chennai, Tamil Nadu.  Blood samples were collected
after an informed consent was obtained. The study
was approved by the ethical committee of the
institute.
Venous blood (20 ml) was collected, defibrinated
and the peripheral blood mononuclear cells (PBMC)
were separated by Ficoll-Hypaque density gradient
centrifugation16. DNA was extracted from a portion of
lymphocytes as described earlier17 and the
concentration and purity of DNA estimated
spectrophotometrically. IL-10 genotyping was studied
using amplification refractory mutation system-
polymerase chain reaction (PCR) method as described
earlier18. Single nucleotide polymorphism (SNP) at the
IL-12B 3’UTR (Taq I) was determined using PCR-
RFLP as described previously19.
           Allele and genotype frequencies were calculated
by direct allele and genotypic counts and expressed as
percentage. Comparison between patients and controls
was done using 2x2 contingency tables and χ2 tests with
Yates correction (Stat calc programme, Epi Info Version
6.04, CDC, Atlanta, GA, USA).  The allele frequencies
were also tested for Hardy-Weinberg equilibrium by
calculating allele frequencies using Pearson’s χ2 tests
with one degree of freedom20.
Results & Discussion
The allele and genotype frequencies of IL-12B
(A/C) polymorphism did not differ significantly between
normal healthy subjects (NHS) and pulmonary
tuberculosis patients (PTB) (P=0.98, 0.95 and 0.59 for
genotypes CC, CA and AA respectively). Similarly, the
allele and genotype frequencies of IL-10-1082 (G/A)
polymorphism did not vary significantly between NHS
Table. Allele and genotype frequencies of IL-12 and IL-10 in normal healthy subjects (NHS) and pulmonary tuberculosis patients (PTB)
IL-12 and IL-10 Allele frequencies Genotype frequency % (n)
polymorphisms NHS PTB Genotypes NHS PTB
(n=143) (n=132) (n=143) (n=132)
IL-12 p40 3’UTR C - 0.42 0.43 CC 19.60 (28) 18.94 (25)
( A/C ) A -  0.58 0.57 CA 44.00 (63) 48.48 (64)
AA 36.40 (52) 32.58 (43)
IL-10 (-1082 G/A)* A - 0.74 0.77 AA 52.14 (73) 56.06 (74)
G - 0.26 0.23 AG 43.57 (61) 41.67 (55)
GG 4.29 (6) 2.27 (3)
n = number of subjects
Number in parentheses represents number of subjects positive in each group
* In case of IL-10 polymorphism, n=140, 3 failed PCR (NHS)
Differences in genotype frequency between PTB and NHS were not significant
and PTB (P=0.51, 0.84 and 0.55 for genotypes AA, AG
and GG respectively) (Table). The genotypes of both
the cytokine polymorphism were within Hardy-
Weinberg equilibrium.
Candidate gene-based case-control studies found
several single nucleotide polymorphisms (SNPs) with
a moderate effect on risk of tuberculosis21. We studied
the associations of single nucleotide polymorphisms
present in two vital cytokine genes namely IL-12B
(3’UTR Taq 1) and IL-10 (-1082). The genotypes of
IL-12B (3’UTR Taq 1) and IL-10 (-1082) did not differ
significantly between patient group and controls. Our
results suggested a lack of association of these single
nucleotide polymorphisms with tuberculosis. The
results were in concordance with a study wherein no
association between IL-12B 3’UTR A/C polymorphism
and tuberculosis was observed both in whites as well
as African American populations22. Similarly, no
association between IL-10 (-1082) and tuberculosis in
Spanish population has been reported18. Contrary to
our results, association between IL-12B intron 2-repeat
marker (ATT) as well as haplotypes composed of IL-
12B promoter, intron 2, intron 4 and 3’UTR alleles
with tuberculosis has been reported in Hong Kong
Chinese population23.  Moreover, heterozygosity for
the -1082 polymorphism of the IL-10 promoter has
been shown to be associated with tuberculosis
susceptibility in a Cambodian population7. The
apparent inconsistency between these studies could be
due to ethnic-specific genetic variations greatly
influencing host immunity to tuberculosis, causing
differential susceptibility to tuberculosis.
Since human susceptibility to tuberculosis is a
complicated polygenic trait, interactive effects between
the polymorphism studied and other SNPs in human
genes (including those in IFN-γ network), need to be
evaluated.
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